CO6491119A2 - Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo - Google Patents

Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo

Info

Publication number
CO6491119A2
CO6491119A2 CO12020130A CO12020130A CO6491119A2 CO 6491119 A2 CO6491119 A2 CO 6491119A2 CO 12020130 A CO12020130 A CO 12020130A CO 12020130 A CO12020130 A CO 12020130A CO 6491119 A2 CO6491119 A2 CO 6491119A2
Authority
CO
Colombia
Prior art keywords
cell culture
cell
culture system
polypeptide
interest
Prior art date
Application number
CO12020130A
Other languages
English (en)
Spanish (es)
Inventor
Leopold Grillberger
Manfred Reiter
Daniel Fleischanderl
Original Assignee
Baxter Healthcare Sa
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa, Baxter Int filed Critical Baxter Healthcare Sa
Publication of CO6491119A2 publication Critical patent/CO6491119A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/006Cell injection or fusion devices
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0056Xeno-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/98Xeno-free medium and culture conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/00051Methods of production or purification of viral material
    • C12N2710/00052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24087ADAMTS13 endopeptidase (3.4.24.87)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
CO12020130A 2009-07-31 2012-02-06 Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo CO6491119A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23031309P 2009-07-31 2009-07-31

Publications (1)

Publication Number Publication Date
CO6491119A2 true CO6491119A2 (es) 2012-07-31

Family

ID=42668436

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12020130A CO6491119A2 (es) 2009-07-31 2012-02-06 Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo

Country Status (22)

Country Link
US (4) US8580554B2 (enExample)
EP (2) EP3480292A1 (enExample)
JP (2) JP5808742B2 (enExample)
KR (2) KR101752789B1 (enExample)
CN (1) CN102549142B (enExample)
AU (1) AU2010277490B2 (enExample)
BR (1) BR112012002137B8 (enExample)
CA (1) CA2769354A1 (enExample)
CO (1) CO6491119A2 (enExample)
DK (1) DK2459697T3 (enExample)
EA (1) EA022219B1 (enExample)
ES (1) ES2705206T3 (enExample)
HR (1) HRP20182165T1 (enExample)
IN (1) IN2012DN00899A (enExample)
MX (2) MX2012001274A (enExample)
NZ (1) NZ597742A (enExample)
PL (1) PL2459697T3 (enExample)
PT (1) PT2459697T (enExample)
SG (1) SG178176A1 (enExample)
SI (1) SI2459697T1 (enExample)
TR (1) TR201900213T4 (enExample)
WO (1) WO2011012725A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3626736T (pt) 2010-07-08 2025-08-11 Takeda Pharmaceuticals Co Método de produção de fvw recombinante de elevado peso molecular na cultura celular
SG191745A1 (en) * 2011-01-17 2013-08-30 Hoffmann La Roche Separation apparatus and use thereof
CA2835053C (en) 2011-05-13 2020-07-07 Octapharma Ag A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii
KR101662412B1 (ko) * 2011-07-01 2016-10-04 암젠 인크 포유동물 세포 배양
CN203129697U (zh) 2013-02-05 2013-08-14 客贝利(厦门)休闲用品有限公司 一种帐篷架杆
CN104136605B (zh) 2011-11-24 2018-08-14 吉尼松公司 与工业制药应用相容的可放大的慢病毒载体生产系统
US9574167B2 (en) 2013-02-15 2017-02-21 Pharyx, Inc. Methods and apparatus for independent control of product and reactant concentrations
CN118388581A (zh) 2013-03-08 2024-07-26 建新公司 治疗性蛋白药物物质的整合连续制造
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
ES2842350T3 (es) 2013-03-19 2021-07-13 Cmc Biologics As Un procedimiento para la producción de un producto (por ejemplo, polipéptido) en un proceso de fermentación de cultivo celular continuo
CA2920934C (en) * 2013-08-30 2022-12-06 Glaxosmithkline Biologicals S.A. Large scale production of viruses in cell culture
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
KR20160146763A (ko) 2014-04-01 2016-12-21 어드밴텍 바이오사이언스 파마큐티카 엘티디에이 부형제로서 칼슘이 첨가되지 않은 factor viii의 안정화
JP2017509659A (ja) 2014-04-01 2017-04-06 アドヴァンテック・バイオサイエンス・ファルマスーティカ・リミターダ 低糖−低グリシンの安定な第viii因子製剤
CN106414719B (zh) * 2014-06-13 2020-02-14 杰特有限公司 生物反应器中重组von Willebrand因子的改进生产
KR20240173213A (ko) * 2016-01-26 2024-12-10 베링거 인겔하임 인터내셔날 게엠베하 연결된 관류 대 연속-유동식 교반-탱크 반응기 세포 배양 시스템
EP3443064A1 (en) * 2016-04-15 2019-02-20 Boehringer Ingelheim International GmbH Cell retention device and method
US20200063086A1 (en) * 2016-12-21 2020-02-27 Hoffmann-La Roche Inc. Growth control of eukaryotic cells
IL321253A (en) 2018-05-01 2025-08-01 Amgen Inc Antibodies with a modulated glycan profile
WO2019239780A1 (ja) * 2018-06-15 2019-12-19 富士フイルム株式会社 細胞培養方法、細胞培養装置、及び生産物の製造方法
BR112021003420A2 (pt) 2018-08-31 2021-05-18 Genzyme Corporation resina cromatográfica estéril e uso da mesma em processos de manufatura
CN113355297A (zh) * 2021-06-23 2021-09-07 吉林冠界生物技术有限公司 一种灌流式培养全悬浮mdck细胞生产重组禽流感病毒的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019512A (en) 1989-03-17 1991-05-28 Baxter International Inc. Spin filter for removing substantially cell-free culture medium from suspension cell culture system
US5626734A (en) 1995-08-18 1997-05-06 University Technologies International, Inc. Filter for perfusion cultures of animal cells and the like
EP1325127B1 (en) 2000-10-02 2009-03-11 Novo Nordisk Health Care AG Method for the production of vitamin k-dependent proteins
AU2002342922A1 (en) * 2001-11-28 2003-06-10 Sandoz Ag Cell culture process
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
AU2006257073B2 (en) 2005-06-17 2011-08-04 Children's Medical Center Corporation ADAMTS13-comprising compositions having thrombolytic activity
SI2522717T1 (sl) * 2006-01-04 2014-05-30 Baxter International Inc. Mediji celične kulture brez oligopeptidov
CA2709890A1 (en) * 2007-12-27 2009-07-09 Andre Giovagnoli Cell culture processes

Also Published As

Publication number Publication date
CA2769354A1 (en) 2011-02-03
US20190153400A1 (en) 2019-05-23
IN2012DN00899A (enExample) 2015-04-03
KR20120038531A (ko) 2012-04-23
WO2011012725A1 (en) 2011-02-03
BR112012002137A2 (pt) 2015-09-15
NZ597742A (en) 2014-02-28
JP5808742B2 (ja) 2015-11-10
JP6177260B2 (ja) 2017-08-09
US9650612B2 (en) 2017-05-16
TR201900213T4 (tr) 2019-02-21
HRP20182165T1 (hr) 2019-03-08
SG178176A1 (en) 2012-03-29
US10745672B2 (en) 2020-08-18
CN102549142B (zh) 2014-07-16
EP2459697B1 (en) 2018-10-17
US20140038264A1 (en) 2014-02-06
BR112012002137B8 (pt) 2020-05-12
SI2459697T1 (sl) 2019-03-29
PT2459697T (pt) 2019-01-21
US10221400B2 (en) 2019-03-05
EP2459697A1 (en) 2012-06-06
EA022219B1 (ru) 2015-11-30
MX353610B (es) 2018-01-18
EA201270213A1 (ru) 2012-06-29
PL2459697T3 (pl) 2019-04-30
AU2010277490A1 (en) 2012-02-09
EP3480292A1 (en) 2019-05-08
US20180051261A1 (en) 2018-02-22
KR101752789B1 (ko) 2017-06-30
CN102549142A (zh) 2012-07-04
US20110086411A1 (en) 2011-04-14
BR112012002137B1 (pt) 2020-04-14
ES2705206T3 (es) 2019-03-22
KR101885046B1 (ko) 2018-08-02
US8580554B2 (en) 2013-11-12
DK2459697T3 (en) 2019-01-28
AU2010277490B2 (en) 2014-08-28
WO2011012725A8 (en) 2011-05-05
KR20170077286A (ko) 2017-07-05
JP2013500710A (ja) 2013-01-10
MX2012001274A (es) 2012-06-01
JP2015062436A (ja) 2015-04-09

Similar Documents

Publication Publication Date Title
BR112012002137B8 (pt) método para produzir um polipeptídeo e/ou vírus de interesse em uma cultura de célula contínua isenta de soro
ES2527173T3 (es) Células de fucosilación deficiente
AR132549A2 (es) Medio de cultivo para células cho libre de suero que comprende ornitina y putrescina, método para cultivar células cho y método in vitro para producir una proteína
AR111785A2 (es) Método in vitro de producción de eritrocitos
AR124871A2 (es) Métodos de fabricación para el control del contenido de lisina c-terminal, galactosa y ácido siálico en proteínas recombinantes
NZ593235A (en) Method for the production of recombinant adenovirus serotype 35
NZ601424A (en) Method for the production of ad26 adenoviral vectors
AR069956A1 (es) Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas
JP2016105737A5 (enExample)
BR112013025086A2 (pt) sistema e métodos de biorreator multifuncional para classificação e cultura de células
CO6680636A2 (es) Método para producir adamts13 recombinante en cultivo celular
JP2015532096A5 (enExample)
MX340242B (es) Proceso mejorado para el cultivo de celulas.
AR074963A1 (es) Sistema y metodo para recuperar informacion relevante.
BR112016027290A2 (pt) métodos para a produção de ramnolipídeos".
JP2015521848A5 (enExample)
MX2020013633A (es) Metodos para producir proteinas recombinantes.
BR112015007319A2 (pt) composições e métodos para produzir glicoproteínas
BR112013028006A2 (pt) método para aumentar a produtividade de células eucarióticas na produção do recombinante fviii
Cai et al. Differential homeostasis of sessile and pendant epithelium reconstituted in a 3D‐printed “GeminiChip”
Peirce et al. Immobilization of carbonic anhydrase for biomimetic CO2 capture in a slurry absorber as cross-linked enzyme aggregates (CLEA)
CL2013002723A1 (es) Metodo de produccion de una particula semejante a virus (vlp) de alfavirus salmonido (sav) en celulas de insecto.
AR085271A1 (es) Procedimiento para la produccion a escala comercial de prrsv
BRPI0914805B8 (pt) método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição
BR112017017303B8 (pt) Método para obtenção de clones de células de alta produtividade